Biologicals and how they revolutionized rheumatology

Wien Med Wochenschr. 2015 Jan;165(1-2):1-2. doi: 10.1007/s10354-015-0343-z.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / economics
  • Biological Products / economics
  • Biological Products / therapeutic use*
  • Biosimilar Pharmaceuticals / economics
  • Biosimilar Pharmaceuticals / therapeutic use
  • Cost Savings / trends
  • Drug Costs / trends
  • Forecasting
  • Germany
  • Humans

Substances

  • Biological Products
  • Biosimilar Pharmaceuticals